Tpst News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tpst. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tpst Today - Breaking & Trending Today

Tempest Therapeutics (NASDAQ:TPST) Earns Buy Rating from HC Wainwright

HC Wainwright restated their buy rating on shares of Tempest Therapeutics (NASDAQ:TPST – Free Report) in a research report sent to investors on Wednesday, Benzinga reports. They currently have a $47.00 price objective on the stock. HC Wainwright also issued estimates for Tempest Therapeutics’ Q1 2024 earnings at ($0.36) EPS, Q2 2024 earnings at ($0.36) […] ....

Worth Venture Partners , Jefferies Financial Group , Tempest Therapeutics Inc , Tempest Therapeutics Company Profile , Northern Trust Corp , Maytech Global Investments , Renaissance Technologies , Sectoral Asset Management Inc , Tempest Therapeutics , Free Report , Financial Group , Tech Global Investments , Trust Corp , Venture Partners , Sectoral Asset Management , Get Free Report , Tempest Therapeutics Daily , Nasdaq Tpst , Reiterated Rating , Hc Wainwright ,

HC Wainwright Boosts Tempest Therapeutics (NASDAQ:TPST) Price Target to $47.00

Tempest Therapeutics (NASDAQ:TPST – Free Report) had its price target lifted by HC Wainwright from $35.00 to $47.00 in a report published on Wednesday morning, Marketbeat reports. HC Wainwright currently has a buy rating on the stock. Tempest Therapeutics Trading Down 8.5 % TPST opened at $3.64 on Wednesday. The stock has a market capitalization […] ....

Geode Capital Management , Millennium Management , Tempest Therapeutics Inc , Worth Venture Partners , Renaissance Technologies , Tempest Therapeutics Company Profile , Susquehanna International Group , Tempest Therapeutics , Free Report , Therapeutics Trading Down , Get Free Report , Capital Management , Venture Partners , Tempest Therapeutics Daily , Nasdaq Tpst , Boost Price Target , Hc Wainwright ,

Tempest Therapeutics (NASDAQ:TPST) PT Raised to $47.00

Tempest Therapeutics (NASDAQ:TPST – Get Free Report) had its price target lifted by research analysts at HC Wainwright from $35.00 to $47.00 in a research note issued to investors on Wednesday, Marketbeat reports. The brokerage presently has a “buy” rating on the stock. Tempest Therapeutics Stock Down 59.3 % Shares of TPST stock opened at […] ....

Tempest Therapeutics Inc , Millennium Management , Geode Capital Management , Tempest Therapeutics Company Profile , Susquehanna International Group , Worth Venture Partners , Renaissance Technologies , Tempest Therapeutics , Get Free Report , Therapeutics Stock Down , Capital Management , Venture Partners , Tempest Therapeutics Daily , Nasdaq Tpst , Boost Price Target , Hc Wainwright ,